Fairhaven Health
Since 2003, Fairhaven Health has been a leading brand of science-based products for trying to conceive couples, including our FH PRO line of fertility supplements and BabyDance Fertility Lubricant, the first ever sperm-friendly lubricant made without parabens. FH PRO for Men and Women are comprehensive, antioxidant-based, and clinically-studied fertility supplements. FH PRO for Men was shown in a clinical study to improve progressive motility by 102%, sperm count by 38% and reduced DNA fragmentation by 17%. Once pregnancy is achieved, we provide a variety of prenatal supplements and our award-winning Milkies nursing products to help new moms meet their breastfeeding goals. Most recently, we have launched our Vaginal Care & Comfort line of paraben-free, isotonic gels to support vaginal health through all life stages. Fairhaven Health is an ISO-13485 certified company with all products manufactured in N. America in GMP-certified facilities, quality and support you can count on. We work with thousands of practitioners and are always happy to send out samples and information.
Live Q&A ‘New Antioxidants in Male Fertility: Efficacy and Novel Molecular Changes‘ with Dr. Ashok Ararwal and FairHaven Health
New Antioxidants in Male Fertility: Efficacy and Novel Molecular Changes
Presented by Dr. Ashok Agarwal, Cleveland Clinic
Infertility affects approximately 15% of couples globally, with 2.5%–12% believed to be solely due to male factors. The speaker is going to discuss the main causes of infertility and the factors responsible for the rise in male infertility. Despite advances in the field of male reproductive health, idiopathic male infertility remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels.
This product was used in both studies mentioned by Dr. Agarwal, click above for more information
Dr. Ashok Agarwal will explain how OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm’s potential to fertilize an egg and develop into a healthy embryo. He will discuss how the use of antioxidants to reduce oxidative stress across a range of etiologies and risk factors of male infertility is gaining much attention. The speaker will share results of two recent clinical trials using antioxidants, including one which examined the effect of antioxidant treatment on the sperm proteome of idiopathic
infertile men.
About Dr. Ashok Agarwal Director, American Center for Reproductive Medicine Staff, Departments of Urology, Ob-Gyn, Immunology and Anatomic Pathology, Cleveland Clinic Foundation
Professor of Surgery (Urology), Lerner College of Medicine and Case Western Reserve University
Ashok Agarwal received his Ph.D. in 1983 from Banaras Hindu University, India. He did his post-doctorate training in Reproductive Biology under a fellowship from The Rockefeller Foundation at Harvard Medical School in Boston, Massachusetts. He was an Instructor in Surgery and then an Assistant Professor of Urology at Harvard Medical School from 1988 to 1992. Ashok was appointed in 1993 by the Cleveland Clinic Foundation, Ohio, as the Head of the Clinical Andrology Center, which over 28 years under his leadership, has become a center of excellence in the United States for the diagnosis of male infertility and fertility preservation of men with oncological conditions. He is board certified as a Clinical Laboratory Director in Andrology by the American Board of Bioanalysis and an Inspector for the College of American Pathologists “Reproductive Laboratory Program” for accreditation of Andrology & IVF Laboratories.
Live Q&A ‘Impact of Antioxidant Supplementation on IVF Outcomes’ with Dr. Botros Peter Rizk and FairHaven Health
Impact of Antioxidant Supplementation on IVF Outcomes
Presented by Dr. Botros Peter Rizk
Dr. Botros (Peter) Rizk is a pioneer in the field of infertility and reproductive medicine with over
30 years of experience. In this lecture, Dr. Rizk discusses how oxidative stress can impact
reproductive health and the role it plays in ART procedures. Dr. Rizk shares recent clinical study
data showing the impact that antioxidants can have on IVF outcomes when added to culture
medium and when taken orally.
Botros Peter Rizk, MD, MA, FRCOG, FRCS, HCLD, FACOG, FACS
Dr. Rizk is experienced infertility and reproductive medicine physician serving patients at
Elite IVF, which has locations in The Woodlands, Odessa, and Houston, Texas, Nashville,
Tennessee, and Fairhope, Alabama. Dr. Rizk is a professor of obstetrics and gynecology and the
head of Reproductive Endocrinology and Infertility and Medical and Scientific Director of In
Vitro Fertilization and Assisted Reproduction at the University of South Alabama. Additionally,
he is Lab Director to Odessa fertility lab at Odessa Regional Medical Center. He also is a faculty
member at Texas Tech University in Odessa, TX.
Dr. Rizk has published over twenty medical textbooks covering various aspects of infertility,
ultrasonography and robotic surgery and is one of the early members of the European Society for
Human Reproduction in addition to being a founding member of Middle East Fertility Society.
Studying under Nobel Laureate Professor Robert Edwards, a recipient of the Nobel prize in
Medicine for the world’s first successful In Vitro fertilization treatment, Dr. Rizk began his
a career in Reproductive Medicine in London and Cambridge and later joined the prestigious
University of Cambridge as faculty from 1990 to 1993. Dr. Rizk is board certified by the
American Board of Obstetrics & Gynecology, the Royal College of Obstetricians & Gynecologists
in England, the Royal College of Physicians & Surgeons of Canada in addition to the American
Board of Bioanalysts in Embryology & Andrology.
Dr. Rizk’s clinical interest and research has focused on ovarian stimulation and is internationally
recognized as a leading authority on ovarian hyperstimulation syndrome (OHSS), having made
original contributions to the pathophysiology and prevention of the condition. His book
dedicated to OHSS is now widely utilized as a standard reference guide. In addition to his
extensive work with OHSS, Dr. Rizk is recognized as a leading authority on endometriosis and
has published over four hundred peer reviewed articles, book chapters, and abstracts over the
past 30 years.
Enhancing Fertility for Couples over 35